Pharvaris N.V. Files June 2025 6-K Report

TL;DR

Pharvaris N.V. (PHVS) filed its June 6-K, confirming 20-F reporting and Dutch HQ.

AI Summary

Pharvaris N.V. filed a Form 6-K on June 27, 2025, to report on its activities for the month of June 2025. The filing indicates that the company is a foreign private issuer and will file its annual reports under cover of Form 20-F. The company's principal executive office is located in Leiden, The Netherlands.

Why It Matters

This filing provides routine updates for investors and stakeholders regarding Pharvaris N.V.'s ongoing compliance and reporting as a foreign private issuer.

Risk Assessment

Risk Level: low — This filing is a routine administrative report and does not contain material financial or operational news.

Key Players & Entities

• Pharvaris N.V. (company) — Filer of the 6-K report
• June 2025 (date) — Reporting period for the 6-K
• 20250627 (date) — Filing date of the 6-K
• Leiden, The Netherlands (location) — Location of the company's principal executive office

FAQ

From the Filing

0000950170-25-090887.txt : 20250627 0000950170-25-090887.hdr.sgml : 20250627 20250627161504 ACCESSION NUMBER: 0000950170-25-090887 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250627 FILED AS OF DATE: 20250627 DATE AS OF CHANGE: 20250627 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pharvaris N.V. CENTRAL INDEX KEY: 0001830487 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: P7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40010 FILM NUMBER: 251086455 BUSINESS ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 BUSINESS PHONE: 31 (0)71 203 6410 MAIL ADDRESS: STREET 1: J.H. OORTWEG 21 STREET 2: 2333 CH LEIDEN CITY: LEIDEN STATE: P7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: Pharvaris, B.V. DATE OF NAME CHANGE: 20201029 6-K 1 annual_general_meeting_2.htm 6-K 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of June 2025 Commission File Number: 001-40010 Pharvaris N.V. (Translation of registrant’s name into English) Emmy Noetherweg 2   2333 BK Leiden   The Netherlands (Address of principal executive office)   Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F ☒ Form 40-F ☐   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐   Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.   Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐   Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. PHARVARIS N.V.   Results of Annual General Meeting of Shareholders   On June 27, 2025, Pharvaris N.V. (the “Company”) held its Annual General Meeting of Shareholders (the “Annual General Meeting”). The final results of each of the agenda items submitted to a vote of the shareholders are as follows: Agenda Item 3   Adoption of Dutch statutory annual accounts for the fiscal year ended December 31, 2024. The Company’s shareholders adopted the Dutch statutory annual accounts for the fiscal year ended December 31, 2024. Agenda Item 4   Appointment of PricewaterhouseCoopers Accountants N.V. as the Company’s external independent auditor for the fiscal year ending December 31, 2025. The Company’s shareholders appointed PricewaterhouseCoopers Accountants N.V. as the Company’s external independent auditor for the fiscal year ending December 31, 2025. Agenda Item 5   Discharge from liability for the Company's directors with respect to the performance of their duties during the fiscal year ended December 31, 2024. The Company’s shareholders discharged the Company’s directors from lia